Skip to main content
Premium Trial:

Request an Annual Quote

Merck to Use HTG s Array Plate Assay Technology

NEW YORK, May 4 (GenomeWeb News) - HTG today said that Merck has licensed its ArrayPlate qNPA (quantitative nuclease protection assay) technology for its drug discovery research.

ArrayPlate qNPA offers multiplexed measurement of 16 mRNA species in each well of a standard 96-well microplate, HTG said.

HTG did not provide financial details of the licensing agreement.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.